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Abstract
The evolution of transcriptional regulators through the recruitment of DNA-binding domains by enzymes is a widely held
notion. However, few experimental approaches have directly addressed this hypothesis. Here we report the reconstruction
of a plausible pathway for the evolution of an enzyme into a transcriptional regulator. The BzdR protein is the prototype of a
subfamily of prokaryotic transcriptional regulators that controls the expression of genes involved in the anaerobic
degradation of benzoate. We have shown that BzdR consists of an N-terminal DNA-binding domain connected through a
linker to a C-terminal effector-binding domain that shows significant identity to the shikimate kinase (SK). The construction
of active synthetic BzdR-like regulators by fusing the DNA-binding domain of BzdR to the Escherichia coli SKI protein
strongly supports the notion that an ancestral SK domain could have been involved in the evolutionary origin of BzdR. The
loss of the enzymatic activity of the ancestral SK domain was essential for it to evolve as a regulatory domain in the current
BzdR protein. This work also supports the view that enzymes precede the emergence of the regulatory systems that may
control their expression.
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Introduction
Regulation of transcription through the action of small
molecules that directly bind to a transcription factor is widespread
in all life forms. A large number of transcriptional regulators
contain a DNA-binding domain fused to an effector-binding
domain. Binding of the effector results in a conformational change,
which influences the properties of the transcription factor and,
accordingly, results in activation or repression of transcription [1].
The effector-binding protein domains of transcriptional regula-
tors appear to have evolved by distinct selective forces. In some
cases, the effector-binding protein domains appear to derive from
catalytic proteins, which may or may not retain the active site
residues in their binding pockets during evolution and thus could
possibly behave as bifunctional proteins [2]. There are also a few
examples of transcriptional regulators that might have evolved
from enzymes that have lost their catalytic activity. In eukaryotes,
we could mention the Gal80 regulator involved in the catabolism
of galactose in Saccharomyces cerevisiae and Kluyveromyces lactis [3], and
TAFII150 protein in Drosophila melanogaster which controls tran-
scription mediated by the RNA polymerase (RNAP)-II [4]. In
prokaryotes, the HutC regulator of Pseudomonas putida, involved in
histidine utilization [5], and the FarR regulator of Escherichia coli,
which controls the expression of Krebs cycle genes and responds to
fatty acids [6], contain effector-binding domains similar to
chorimaste lyases [2]. However, the evolutionary pathways giving
rise to these regulators have not yet been reproduced in the
laboratory.
Anaerobic pathways provide reliable model scenarios to study
protein evolution since they may preserve relics of ancient events
occurring on early anaerobic Earth. In an effort to understand the
evolution of regulators, we have reconstructed the most probable
evolutionary pathway followed by the BzdR regulator. The BzdR
protein of the facultative anaerobe b-Proteobacterium Azoarcus sp.
CIB is the prototype of a new subfamily of transcriptional
regulators. This regulator controls the expression of genes involved
in the aerobic or anaerobic degradation of benzoate [7].
The predicted domain organization of BzdR consists of an N-
terminal region (NBzdR, residues 1–90), homologous to the DNA-
binding domain of members of the helix-turn-helix (HTH)-XRE
transcriptional regulator, connected through a linker sequence to a
C-terminal region (CBzdR, residues 131–298), This C-terminal
region shows 23% sequence identity with the E. coli shikimate
kinase I (SKI) (aroK gene product). In addition CBzdR conserves
the SKI P-loop-containing nucleoside triphosphate hydrolase fold,
the Walker-A motif and the Gly present in the Walker B-motif of
purine nucleotide-binding proteins, and recognizes the inducer
molecule benzoyl-CoA (Figure 1) [7,8]. In this work, we have
experimentally reproduced the most likely evolutionary pathway
followed by the BzdR protein. First, we show that NBzdR and
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CBzdR are real functional domains able to bind DNA and the
effector molecule, respectively. We then constructed functionally
active synthetic BzdR-like regulators by fusing the DNA-binding
domain of BzdR to E. coli SKI protein as the effector-binding
domain. The observed functionality of these synthetic regulators
provides strong support for a role of an ancestral SK enzyme in the
evolutionary origin of the BzdR protein.
Materials and Methods
Strains, Plasmids, Growth Conditions, and Molecular
Biology Procedures
The E. coli strains and plasmids used in this work are listed in
Table 1. The construction of recombinant plasmids featuring the
BzdR modules and the chimeras Q1, Q1DL and Q2 is detailed in
the supplementary materials. E. coli cells were grown on Luria-
Bertani (LB) [9] or M63 [10] medium supplemented with the
appropriate carbon source at 37uC. Anaerobic growth in LB
medium using 10 mM nitrate as the final electron acceptor was
achieved as previously reported [7]. Standard molecular biology
techniques were performed as described previously [9].
Enzymatic Assays
b-Galactosidase activities were measured using permeabilized
cells as described by Miller [10]. Shikimate kinase assays were
performed according to previously established procedures [11]
with the modifications detailed below. Plasmid pJCD-PN was used
as as supercoiled PN template for in vitro transcription assays
conducted as previously described [12].
Gel Retardation and DNase I Footprinting Assays
The PN DNA probe was obtained and mixed with the purified
proteins at the concentrations indicated in each assay according to
a previously described procedure [7].
Recombinant Plasmid Constructions
To clone the NBzdR, NBzdRL and CBzdR domains, NbzdR,
NBzdRL and CbzdR fragments were first PCR amplified from
pECOR7 plasmid using the oligonucleotide pairs 59HisReg (59-
CGGGATCCTTTCCAACGATGAGAACTCATCAC-39; engi-
neered BamHI site underlined)/N1BzdR (59-GGGAAGCTTT-
CACTCCGCCTCCTCGCGCACG-39; engineered HindIII site
underlined), 59HisReg (see above)/N2BzdR (59-
GGGAAGCTTTCACCTGCGCGCGCTTCGCCCC-39; engi-
neered HindIII site underlined) and 59C2 (59-CGGGATCCT-
CAGCGTGCCAGGACTTCGAGG-39; an engineered BamHI is
underlined)/39HisReg (59-GGGAAGCTTTCAGCGTGCCAG-
GACTTCGAGG-39; engineered HindIII site underlined). Next,
the PCR amplified products were cloned into the pQE32 vector
by BamHI/HindIII double digestion, giving rise to plasmids
pQE32-His6NBzdR, pQE32-His6NBzdRL and pQE32-
His6CBzdR, respectively. The NbzdR and NBzdRL fragments were
also subcloned under the control of the Plac promoter into the
pKC01 vector by EcoRI/HindIII double digestionyielding plas-
mids pCK01NBzdR and pCK01NBzdRL, respectively. The aroK
gene that encodes the SKI enzyme was PCR amplified from the E.
coli CC118 genome using 59His-aroK oligonucleotides (59-
CGGGATCCTTGCAGAGAAACGCAATATCTTT-39; engi-
neered BamHI site underlined)/59aroKquim (59-AACTGCAGT-
TAGTTGCTTTCCAGCATGTGAATA-39; engineered PstI un-
derlined) and then cloned into the pQE32 vector by BamHI/PstI
double digestion, giving rise to plasmid pQE32- His6SKI.
To construct the Q1 and Q1DL chimeras, NBzdR, NBzdRL and
aroK were first PCR amplified from pECOR7 plasmid and aroK
from the E. coli CC118 genome using the oligonucleotide pairs
59HisReg (see above)/newN1quim (59-
GGGGTACCCTCCGCCTCCTCGCGCACG-39; engineered
KpnI site underlined) or 59HisReg (see above)/59N2qim (59-
GGGGTACCCCTGCGCGCGCTTCG-3`; engineered KpnI site
underlined) and 39aroKqim* (59-GGGGTACCATGGCAGA-
GAAACGCAATATCTTT-39; engineered KpnI site underlined)/
59aroKquim (see above), respectively. The NBzdR and NBzdRL
amplified products were cloned into the pGEM-Teasy vector by
BamHI/KpnI double digestion, giving rise to plasmids pGEMT-
NBzdR and pGEMT-NBzdRL, respectively. The aroK amplified
product was then cloned into the pGEMT-NBzdR and pGEMT-
NBzdRL vectors by KpnI/PstI double digestion, giving rise to
plasmids pGEMT-Q1DL and pGEMT-Q1. These constructions
were digested using BamHI and PstI enzymes to subclone the
Q1DL and Q1 genes with N-terminal His6-tag into the pQE32
plasmid, generating plasmid pQE32-His6Q1DL and pQE32-
His6Q1.
The Q2 chimera containing the Asp168Ala substitution was
constructed by directed PCR mutagenesis using pQE32-His6Q1
plasmid as template. Fragment A spannings from the start codon
of aroK to the codon that encodes the Asp36 residue was PCR-
amplified with oligonucleotides 39aroKquim (anneals at the 59-end
of the aroK start codon) and 39D36A (59-AATCTCTTGAGCG-
GAATCGTAAAATTC-39; anneals at the region spanning codon
Asp36 of the aroK gene and replaces it with an Ala codon).
Fragment B, spanning from the codon that encodes the Asp36
residue to the 39-end of aroK, was PCR-amplified with oligonu-
cleotides 5’D36A (59-GAATTTTACGATTCCGCTCAAGA-
GATT-39; anneals at the region spanning codon Asp36 of the
aroK gene and replaces it with an Ala codon) and 5’aroKquim
(anneals at the 39-end of aroK). A second round of PCR
amplification uses as templates the A and B fragments, and as
primers the 3’aroKquim and 5’aroKquim oligonucleotides, which
anneal at the start and stop codon of the aroK gene, respectively.
Figure 1. Modular architecture of the BzdR derivatives. Diagram
showing the modular architecture of the BzdR protein, its NBzdR,
NBzdRL and CBzdR domains, and the Q1, Q2 and Q1DL chimeras. The N-
terminal domain (NBzdR), C-terminal domain (CBzdR) and linker region
of BzdR are indicated in orange, blue and green, respectively. The E. coli
SKI enzyme is shown in violet, and the Asp168Ala substitution in the Q2
chimera is indicated by an asterisk in red.
doi:10.1371/journal.pone.0057518.g001
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The resulting aroK mutant gene that contains the Asp36Ala
substitution was KpnI/PstI-double digested, replacing the wild-type
aroK gene cloned in pQE32-His6Q1 to give rise to plasmid pQE32-
His6Q2.
All constructions were confirmed by DNA sequencing.
Shikimate Kinase Activity Assays
Shikimate kinase activity was determined at 25uC by coupling
the release of ADP to pyruvate kinase (EC 2.7.1.40) and lactate
dehydrogenase (EC 1.1.1.27) reactions. Shikimate-dependent
oxidation of NADH was monitored at 340 nm (e= 6180 M21
cm21). The standard assay mixture contained (final concentration)
50 mM triethanolamine hydrochloride/KOH buffer, pH 7.0,
50 mM KCl, 5 mM MgCl2, 1.6 mM shikimate, 2.5 mM ATP,
1 mM phosphoenolpyruvate, 0.1 mM NADH, 3 units of pyruvate
kinase (Sigma)/ml, 2.5 units of lactate dehydrogenase (Sigma)/ml,
and the target protein to be assayed. Km values for shikimate were
obtained from the Lineweaver-Burk plot [13]. Although it has
been described that E. coli SKI has a high Km (5–20 mM) for
shikimate, this value was obtained using an SKI isolated as a
heterologous mix of oligomers [14]. Our results show that the
His6-SKI has a Km for shikimate (0.4 mM) similar to that reported
previously for the E. coli SKII [15]. In the competition assays,
benzoyl-CoA or AMP were added at a 10 mM concentration to
the standard assay conditions, and shikimate kinase activity was
compared to that obtained in the absence of these inhibitors.
Table 1. Bacterial strains and plasmids used in this work.
Strain or plasmid Relevant phenotype and/or genotypea Reference
E. coli strains
DH5a endA1 hsdR17 supE44 thi-1 recA1 gyrA(Nalr) relA1D(argF-lac) ø80dlacD(lacZ)M15 [9]
M15 Strain for regulated high level expression with pQE vectors Qiagen
MC4100 F2, araD319 D(argF-lac)U169 rpsL150(Smr) relA1 flbB5301 deoC1 ptsF25 rbs [29]
AFMC MC4100 spontaneous Rfr [30]
AFMCPN Rf
r, Kmr, AFMC harbouring PN::lacZ translational chromosomal fusion [31]
ALO807 F2, aroL478:Tn10 aroK17:Cmr [18]
CC118 Rfr, Spr, D(ara-leu) araD, DlacX74, galE, galK, thi-1, rpsE, rpoB, argE (Am), recA1 [32]
Plasmids
pQE32 Apr, oriColE1, T5 promoter lac operator, l to/E. coli rrnB T1 terminators Qiagen
pQE32-His6BzdR Ap
r, pQE32 derivative harboring the His6-bzdR gene [7]
pQE32-His6NBzdR Ap
r, pQE32 derivative harboring the His6-NbzdR fragment This work
pQE32-His6NBzdRL Ap
r, pQE32 derivative harboring the His6-NbzdRL fragment This work
pQE32-His6CBzdR Ap
r, pQE32 derivative harboring the His6-CbzdR fragment This work
pQE32-His6Q1 Ap
r, pQE32 derivative harboring the His6-Q1 gene This work
pQE32-His6Q2 Ap
r, pQE32 derivative harboring the His6-Q2 gene This work
pQE32-His6Q1DL Ap
r, pQE32 derivative harboring the His6-Q1DL gene This work
pQE32-His6SKI Ap
r, pQE32 derivative harboring the His6-aroK gene This work
pJCD-PN Ap
r, pJCD01 derivative harboring a 585-bp EcoRI [12]
pQE60-His6-FNR* Ap
r, pQE60 derivative that harbors the His6-fnr* gene [12]
pREP4 Kmr, plasmid that expresses the lacI repressor Qiagen
pECOR7 Apr, pUC19 harboring a 7.1-kb DNA fragment containing the bzdRNO genes [31]
pGEM-Teasy Apr, oriColE1, lacZa, vector for cloning PCR products Promega
pGEMT-NBzdRL Apr, pGEM-Teasy derivative harboring the NbzdRL fragment This work
pGEMT-NBzdR Apr, pGEM-Teasy derivative harboring the NbzdR fragment This work
pGEMT-CBzdR Apr, pGEM-Teasy derivative harboring the CbzdR fragment This work
pGEMT-SKI Apr, pGEM-Teasy derivative harboring the aroK fragment This work
pGEMT-Q1 Apr, pGEM-Teasy derivative harboring the Q1 fragment This work
pCK01 Cmr, oripSC101, low copy number cloning vector, polylinker flanked by NotI sites [33]
pCK01BzdR Cmr, pCK01 derivative harboring a DNA fragment containing the bzdR gene [7]
pCK01Q1 Cmr, pCK01 derivative harboring the Q1 gene This work
pCK01Q2 Cmr, pCK01 derivative harboring the Q2 gene This work
pCK01NBzdR Cmr, pCK01 derivative harboring the NBzdR gene This work
pCK01NBzdRL Cmr, pCK01 derivative harboring the NBzdRL gene This work
pSJ3PN Ap
r, pSJ3 derivative harbouring the translational fusion PN::lacZ [7]
Apr, ampicillin resistant; Cmr chloramphenicol resistant; Kmr, kanamycin resistant; Nalr, nalidixic acid; Rfr, rifampicin resistant; Smr, streptomycin resistant; Spr,
spectinomycin resistant.
doi:10.1371/journal.pone.0057518.t001
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Fluorescence Assays
Binding of benzoyl-CoA to CBzdR was determined by
monitoring the change in protein fluorescence upon ligand
addition. Measurements were obtained in an SML-Amicon 8000
spectrophotometer using quartz cuvettes and 0.2-cm excitation
and 1-cm emission path lengths (lexcitation = 275 nm and lemission
312 nm; slit widths = 5 nm). Titrations were performed at 25uC by
adding a benzoyl-CoA stock solution to 0.4 ml of 20 mM Tris-
HCl, pH 8.0, 100 mM KCl containing CBzdR (1 mM initial
concentration). The final ligand concentration ranged from 0 to
300 mM. Corrections were made for protein dilutions, background
signal, and for the instrument response as indicated by the
manufacturer. Control titrations with buffer alone produced no
change in the emission signal after correlation. The Kd value for
benzoyl-CoA in CBzdR was calculated by non-linear regression
using the equation for a one-site saturation model ([L]b/
[P]t = ([L]free/Kd+[L]free) implemented in the GraphPad Prism
software (GraphPad software, San Diego); where [L]b, is the
concentration of bound ligand; [P]t, the total protein concentra-
tion, and [L]free, the concentration of free ligand. The fraction of
bound ligand was calculated as (Io2I)/(Io2Imin); where Io is the
maximum CBzdR fluorescence intensity (no ligand added); I is the
fluorescence intensity after addition of an aliquot of ligand, and
Imin is the fluorescence intensity at saturating concentration of
ligand (this value was estimated by nonlinear regression to a single
hyperbolic decay curve). The data obtained in at least three
experimental trials were averaged to calculate the dissociation
constant.
Results and Discussion
NBzdR Is a Functional DNA-Binding Domain
To confirm our hypothesis that the molecular architecture of
BzdR arises from the fusion of two individual functional domains,
the NBzdR and CBzdR domains were expressed, purified and
characterized as independent proteins (Figure 1). Purified NBzdR
protein was able to bind to the operator region of the PN promoter,
as illustrated by gel shift (data not shown) and DNase I footprinting
experiments (Figure 2A). The expression of NBzdR in E. coli cells
with a chromosomal PN::lacZ fusion elicited the same repression of
the PN promoter observed in cells expressing the entire BzdR
regulator (Figure 2B). In vitro transcription experiments also
revealed the ability of NBzdR to inhibit the PN promoter
(Figure 2C). The predicted five a helices of NBzdR constitute
the minimal structural domain since deletion of helix 5 (residues 77
to 86) did not allow for the production in E. coli of a stable protein
that could be detected by SDS-PAGE (not shown).
We observed that when NBzdR was fused to the linker region,
designated NBzdRL (residues 1 to 130; Figure 1), it was also able
to repress the activity of PN both in vivo and in vitro (Figure 2B and
Figure 2C). Moreover, NBzdRL showed greater protection to this
promoter (operator regions I and II) than NBzdR and similarly to
that observed for complete BzdR protein (Figure 2A). Gel shift
experiments also revealed that NBzdRL was able to retard the
migration of the PN promoter at lower concentrations than those
required for NBzdR (data not shown). These results suggest that
the BzdR linker sequence, whose main function is to facilitate
interdomain communication [8], might also play a role in
stabilization and binding of the N-terminal domain to the target
DNA.
BzdR is a dimer in solution [8]. To test whether this property is
conferred by the N-terminal domain, we examined the association
state of the NBzdR and NBzdRL proteins. Sedimentation velocity
experiments revealed that both proteins sedimented as single
species with s-values of 1.8 and 2.3 S, respectively. Also,
sedimentation equilibrium experiments confirmed that these
species were dimers (Figure S1), demonstrating that BzdR
dimerization is an intrinsic property of the N-terminal domain.
We should mention that benzoyl-CoA was unable to rescue the
repression caused by NBzdR or NBzdRL over the PN promoter
both in vitro (Figure 2C) and in vivo (data not shown), confirming
that NBzdR is not the target of the inducer molecule and,
therefore, behaves as a super-repressor. All of these results suggest
that NBzdR is a true functional domain that retains the ability of
native BzdR protein to bind the PN promoter and repress its
activity.
CBzdR Is a Functional Benzoyl-CoA-Binding Domain
The modelled 3D structure of CBzdR suggests the presence of a
deep groove that could interact with the benzoyl-CoA inducer
molecule [7], triggering a conformational change in BzdR protein
[8]. To establish if effector binding was specific of the C-terminal
domain of BzdR, we investigated whether CBzdR would interact
with benzoyl-CoA. As expected, fluorescence emission by CBzdR
was dramatically modified upon incubation with benzoyl-CoA
(Figure S2). Based on the structural model for CBzdR [7],
fluorimetry data could be fitted to a single binding site, indicating
the formation of a weakly bound CBzdR-benzoyl-CoA complex
(Kd 203635 mM) as previously observed for the parent BzdR
regulator (Kd 157658 mM) [8]. This suggests that benzoyl-CoA
induces a conformational change in CBzdR and that it therefore,
retains its effector-binding ability in the absence of the NBzdR
domain, thus behaving as an independent functional domain.
Analytical ultracentrifugation experiments revealed that CBzdR
behaves as a single species with an s-value of 1.8 S, compatible
with a globular monomer (Figure S3). The observation that
CBzdR is a monomer that undergoes conformational changes in
the presence of its cognate ligand (benzoyl-CoA), resembles the
behaviour of SKs which undergo extensive conformational
changes in the presence of their substrates, i.e., ATP and
shikimate [8]. However, despite this conserved similarity with
SKs, CBzdR showed no detectable shikimate kinase activity
(Figure S4A).
The Q1 Chimera: a Bifunctional Regulator that Controls
the PN Promoter in vitro
The results described above demonstrate that the organization
of BzdR is modular and shaped by two functional domains, i.e.,
NBzdR, which binds to the target promoter and CBzdR, which
recognizes benzoyl-CoA as its inducer molecule. This molecular
architecture suggests that BzdR may have arisen from the fusion of
an HTH-XRE DNA-binding domain to a protein structurally
resembling SK or an ancestor of this enzyme. The structural
similarity between ATP and shikimate, the two substrates of SK,
and the two ends of the benzoyl-CoA molecule, i.e., 3P-ADP and
the benzoyl group, suggest that the latter could also be recognized
by the SK enzyme. In agreement with this hypothesis, we
previously observed that benzoyl-CoA inhibits (by 44%) E. coli SKI
activity in a similar manner to AMP (34% inhibition), a well-
known SK inhibitor [11], suggesting that benzoyl-CoA can be
considered a newly identified ligand of the well-studied SK
enzyme.
To unravel the evolutionary pathway that could have given rise
to the current BzdR regulator, we used a protein engineering
approach and constructed the chimeric protein Q1 by the fusing
NBzdRL to E. coli SKI protein (Figure 1). Interestingly, Q1
showed SK activity yielding a Km for shikimate of 0.6 mM, similar
to that exhibited by E. coli SKI purified at our laboratory (Km
Evolution of the BzdR Regulator
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0.4 mM) (Figure S4A). The enzyme activity of the SK domain in
the Q1 chimera was also demonstrated in vivo in an E. coli aroK aroL
double mutant strain lacking SK activity that is unable to grow in
minimal medium since it cannot synthesize aromatic amino acids
[11]. E. coli aroK aroL cells transformed with a plasmid that
expressed the Q1 protein were observed to grow in glycerol-
containing minimal medium (Figure S4B), indicating that Q1 was
able to rescue the lack of SK activity in the mutant strain.
In analytical ultracentrifugation experiments, Q1 protein
behaved as a single species with an s-value of 3.7 S consistent
with a protein dimer (Figure S3). This finding is in agreement with
the fact that this chimeric protein contains the NBzdR homodi-
meric domain, and reveals that dimerization does not prevent the
catalytic activity of the monomeric SKI enzyme.
The Q1 chimera was able to bind to the three operator regions
of the PN promoter conferring similar protection to that shown by
the BzdR regulator (Figure 3A). In addition, it was capable of
inhibiting PN promoter activity in vitro (Figure 3B, lanes 2-3).
Accordingly, we can conclude that both domains are fully and
separately active in the Q1 chimera.
It is well known that SK enzymes undergo profound confor-
mation changes when they interact with their substrates, ATP-
Mg2+ and shikimate. The binding of shikimate leads to a structural
state (loaded conformation) that, in the presence of ATP-Mg2+, is
maintained for a short period of time sufficient to trigger the
catalytic reaction to produce 3P-shikimate. The enzyme subse-
quently recovers its starting structural state (unloaded conforma-
tion) (Figure S5) [16,17]. Since the Q1 chimera is able to bind and
inhibit the activity of the PN promoter in the absence of shikimate
and ATP (Figures 3A and 3B), we anticipated that the presence of
shikimate alone could provoke a conformational change in the SK
domain, i.e., to a loaded-like conformation, that would lead to the
release of the Q1 protein from the PN promoter. When increasing
concentrations of shikimate were added to the in vitro transcrip-
tion assay mix, significant PN promoter de-repression was observed
(Figure 3B, lanes 4–6). Moreover, this de-repression was not
observed when the Q1 chimera was replaced with Q1DL protein
(Figure 3B, lanes 10–12), a new chimera lacking the linker region
between the NBzdR and SK domains (Figure 1). These data
suggest that the Q1 chimera is a bifunctional regulator that
controls PN promoter activity and responds to shikimate as an
inducer molecule in vitro by generating a conformational change
transmitted to the DNA-binding domain through the linker
region. Interestingly, benzoyl-CoA was also shown to offset the
Q1-dependent repression of PN (Figure 4, lane 5) with an efficiency
similar to that shown by shikimate (Figure 4, lane 4) but lower than
that observed for the native BzdR (Figure 4, lane 11). As
previously noted for BzdR [7], benzoate could not mimic the
Figure 2. The N-terminal domain of BzdR is a functional DNA-binding domain. A. DNase I footprinting experiments were performed using
the PN probe and the purified regulators His6-BzdR (control), His6-NBzdR, and His6-NBzdRL. The figure shows the results of footprinting assays
conducted in the absence of the regulators (lane C), or the presence of 50, 100, or 200 nM of His6-NBzdR (lanes 1 to 3, respectively) or His6-NBzdRL
(lanes 4 to 6, respectively). Lanes 7 and 8 are footprinting assays containing 50 and 100 nM of purified His6-BzdR. Lane AG shows the A+G Maxam and
Gilbert sequencing reaction. Protected regions (I, II, and III) are indicated with brackets. The 210 box and the transcription initiation site (+1) of the PN
promoter are also shown. Phosphodiester bonds hypersensitive to DNase I cleavage are indicated by asterisks. B. In vivo effect of the N-terminal
domain of BzdR on the repression of the PN promoter. E. coli AFMCPN cells (containing a PN::lacZ fusion chromosome insertion of the) harboring
plasmid pCK01BzdR (BzdR), pCK01NBzdR (NBzdR) or pCK01NBzdRL (NBzdRL) or the control plasmid pCK01 (-), were grown anaerobically in LB
medium until the mid-exponential culture phase. b-galactosidase activity is expressed in Miller units. Results from three independent experiments
(n= 3) and errors bars are shown. C. Effect of BzdR, NBzdR and NBzdRL on in vitro transcription from PN. Multiple-round in vitro transcription reactions
were performed using the pJCD-PN plasmid template, which produces a 184-nt mRNA from PN (arrow), 50 nM E. coli RNAP, and 20 nM Fnr* activator.
Transcription reactions were carried out in the absence of repressor (lane -) or presence of 40 nM purified His6-BzdR (lanes BzdR), His6-NBzdR (lanes
NBzdR) or His6-NBzdRL (lanes NBzdRL) and in the absence (-) or presence (+) of 2 mM benzoyl-CoA.
doi:10.1371/journal.pone.0057518.g002
Evolution of the BzdR Regulator
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inducer effect of its CoA derivative (benzoyl-CoA) in the Q1
protein (Figure 4, lane 6), emphasizing the importance of the CoA
moiety in effector recognition.
The observation that CBzdR lacks SK activity (Figure S4A)
raises the question of whether the existence of such activity in the
Q1 chimera may interfere in vivo with effector-dependent de-
repression of the PN promoter. This possibility was confirmed by
Figure 3. In vitro and in vivo effects of the Q1, Q1DL and Q2 chimeras on the PN promoter. (A) DNase I footprinting experiments performed
out using the PN probe and the purified regulators His6-BzdR (control) and His6-Q1. The figure shows the results of footprinting assays conducted in
the absence of the regulators (lane C), or presence of 25, 50, 100, and 200 nM of His6-BzdR (lanes 1 to 4, respectively) or His6-Q1 (lanes 5 to 8,
respectively). Lane AG shows the A+G Maxam and Gilbert sequencing reaction. Protected regions (I, II, and III) are indicated by brackets. The -10 box
and the transcription initiation site (+1) of the PN promoter are also shown. Phosphodiester bonds hypersensitive to DNase I cleavage are indicated by
asterisks. (B) In vitro effect of the Q1 and Q1DL chimeras on the activity of PN. Multiple-round in vitro transcription reactions were performed using the
pJCD-PN plasmid template, which produces a 184-nt mRNA from PN (arrow), 50 nM E. coli RNA polymerase (RNAP), and 20 nM Fnr* activator [12].
Transcription reactions were conducted in the absence of chimeric regulator (lane 1) or presence of 25 nM (lane 2) or 50 nM (lanes 3–12) of purified
His6-Q1 or His6-Q1DL proteins. Shikimate (S) or shikimate plus ATP (S+ATP) were added at 1 mM (lanes 4 and 7), 2 mM (lanes 5 and 8) or 4 mM (lanes
6, 9, 11 and 12). (C) In vivo effect of BzdR (control) and the Q1 and Q2 chimeras on the activity of the PN promoter. b-galactosidase activity (in Miller
units) of E. coli MC4100 cells harboring plasmid pSJ3PN (PN::lacZ) and the plasmids pCK01BzdR (BzdR), pCK01Q1 (Q1), pCK01Q2 (Q2), or the control
plasmid pCK01 (-). Cells were grown anaerobically until mid-exponential phase in LB medium supplemented, when indicated, with 5 mM shikimate
(S). Results from three independent experiments (n= 3) and errors bars are shown. (D). In vitro effect of the Q2 chimera on the activity of PN. In vitro
transcription reactions were performed as in panel B, in the absence of Q2 (lane 1) or presence of 25 nM (lane 2) or 50 nM (lanes 3–9) of purified His6-
Q2 protein. Shikimate (S) or shikimate plus ATP (S+ATP) were added at 1 mM (lanes 4 and 7), 2 mM (lanes 5 and 8) or 4 mM (lanes 6 and 9).
doi:10.1371/journal.pone.0057518.g003
Figure 4. Effect of different ligands on BzdR-, Q1- or Q2-mediated repression of PN. In vitro transcription reactions were run as in Figure 2B,
in the absence of repressor proteins (lane 2) or presence of 40 nM purified His6-Q1 (lanes 3 to 6), His6-Q2 (lanes 7 to 10) or His6-BzdR (lanes 11 to 14).
The ligands shikimate (S) (lanes 4, 8, 12), benzoyl-CoA (BCoA) (lanes 5, 9, 11), and benzoate (Bz) (lanes 6, 10) were added at 1 mM; ATP was added at
4 mM (lane 13). Lanes -, no ligand added. Lane 1, control assay without RNAP.
doi:10.1371/journal.pone.0057518.g004
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monitoring PN promoter activity in E. coli cells expressing the
PN::lacZ reporter fusion and the bifunctional Q1 chimera. It was
observed that Q1 protein inhibited the activity of PN as efficiently
as the control BzdR repressor even after the addition of shikimate
to the culture medium (Figure 3C). These data strongly suggest
that the presence in the cell of both substrates of SK, i.e., shikimate
and ATP-Mg2+, prevents de-repression of the PN promoter. The
lack of PN induction by shikimate in vivo was also confirmed in vitro
when ATP-Mg2+ and shikimate were added together to the
transcription assay (Figure 3B, lanes 7–9). These results are in
agreement with the rapid conformational changes observed in the
SK enzyme after binding of shikimate and ATP-Mg2+ during
catalysis [18,19], and suggest the SK domain of the Q1 protein
does not remain in the loaded-like conformation (Figure S5) for
sufficient time to trigger the release of the repressor from the target
promoter.
Taken together, these results confirm that the SK activity of the
Q1 regulator prevents effector-specific de-repression of the target
promoter by shikimate under physiological conditions.
Evolving the Q1 Chimera towards a BzdR-like Regulator:
the Q2 Chimera
The results reported above suggest that CBzdR may have
evolved from an SK-like enzyme that lost its enzyme activity while
maintaining its benzoyl-CoA binding ability to efficiently control
the PN promoter. To simulate the predicted molecular history of
BzdR in the laboratory, we engineered a Q1 derived protein
containing a single mutation that abolished its enzyme activity.
Since SK activity is strictly dependent on Mg2+, and binding of
this metal requires one Thr and two Asp conserved residues [19],
we engineered a new synthetic protein, a so-called Q2 chimera
(Figure 1), by replacing the Asp168 residue of the Q1 protein
(corresponding to Asp36 of SKI) with an Ala residue. This
substitution avoids Mg2+ binding while maintaining the overall 3D
structure of the SK domain. As expected, the purified Q2 protein
showed no SK activity (Figure S4A), but was still able to efficiently
inhibit the in vitro activity of the PN promoter (Figure 3D, lanes 2–
3). The addition of shikimate or benzoyl-CoA (but not benzoate) to
the in vitro transcription reaction released the repression of the PN
promoter (Figure 3D, lanes 4–6; Figure 4, lanes 8–10) suggesting
that the SK domain of Q2 retained its ability to bind both ligands
and transfer the corresponding conformational changes to the
NBzdR domain. Interestingly, shikimate also attenuated the
repression exerted by Q2 even in the presence of ATP-Mg2+
(Figure 3D, lanes 7–9). Moreover, in vivo experiments revealed that
the addition of shikimate to the culture medium of E. coli cells
expressing the PN::lacZ reporter fusion and the Q2 chimera
reduced the repression exerted by Q2 (Figure 3C), a behaviour not
observed for the Q1 chimera. These results indicate that when the
PN promoter is repressed by the Q2 chimera it can be de-repressed
in vivo by shikimate.This observation is consistent with the fact that
the catalytically inactive SK domain of the synthetic Q2 regulator
can adopt a permanent loaded-like conformation under physio-
logical conditions when shikimate is present, thus triggering the
release of the repressor from the target promoter.
All these results point to a role of the Q2 chimera as a synthetic
transcriptional regulator that can control the PN promoter by
recognizing shikimate and benzoyl-CoA as inducer molecules.
Shikimate and ATP were not effective CBzdR ligands since they
were unable to significantly impair the BzdR-dependent inhibition
of PN (Figure 4, lanes 12–13). Thus, the Q2 chimeric protein
represents a BzdR-like regulator with a broader effector-binding
range and is a likely intermediate in the evolutionary history of the
current BzdR protein.
Several lines of research have suggested that early enzyme forms
exhibited broad substrate specificity, or ‘‘substrate ambiguity’’,
and later diverged to give rise to the specific enzymes we know
today [20,21,22,23]. Proteins acquire new functions without losing
their original function, and gene duplication may follow the
emergence of a new function, rather than initiate it [24]. In effect,
it is known that the SK domain can occur as an independent
enzyme, e.g., AroK and AroL proteins in bacteria [15], or as a
Figure 5. Proposed model for the evolutionary origin of the BzdR protein. The red arrows represent fusion between a shikimate kinase
ancestor and a DNA-binding domain of the HTH-XRE family. This fusion rendered a protein equivalent to the Q1 chimera. A series of mutations led to
the loss of enzyme activity (chimera Q1) and finally to increase in the affinity of the protein for the inducer benzoyl-CoA. Sk: shikimate; 3-P-Sk: 3-
phosphoshikimate; Bz-CoA: benzoyl-CoA.
doi:10.1371/journal.pone.0057518.g005
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domain of multifunctional enzymes, e.g., AROM protein in
Ascomycetes [25]. Moreover, the duplication of genes coding for
SK-like domains is very common in plants and some of these
proteins have acquired novel functions, e.g., SKL1, which seems
essential for chloroplast biogenesis and SKL2, which encodes a key
protein for species-adaptive molecular evolution in Arabidopsis
thaliana [26]. Although these duplications are less frequent in
prokaryotes, E. coli also has two SKs, and one of these (SKI) could
play a role in an as yet unknown cell function since aroK mutants
are resistant to mecillinam [27]. In contrast with examples
proposed previously whereby an ancestral SK evolved into a
novel enzyme, our work shows that the SK domain could also
have evolved to give rise to a regulatory protein. We suggest that
SK behaves as a ‘‘stem’’ protein domain, able to interact with
different substrates and thus facilitating the acquisition of new
functions over time. In effect, a similar SK domain has also been
detected in a putative regulator (plpp0115 gene product) in the c-
proteobacterium Legionella pneumophila [28].
Concluding Remarks
We report the reconstruction of an analogue of an ancestral
protein that could have generated one of the domains of the
current BzdR regulator, whose modular architecture comprises
two independent functional domains, i.e., a DNA-binding domain
(NBzdR) and an effector-binding domain (CBzdR) (Figure 5). The
fact that we were able to construct and characterize a bifunctional
Q1 regulator strongly suggests that fusion of an HTH-XRE DNA-
binding domain to an SK domain was a major step in the
evolution of BzdR. In addition, this SK domain was found to
behaves as a stem protein domain able to interact with different
substrates. The finding that SK recognizes benzoyl-CoA provides
additional evidence for our hypothesis. However, the loss of
enzyme activity of the SK domain may have been a critical event
to improve the efficiency of the ancestral BzdR regulatory protein.
Indeed, this was indicated by the catalytically-inactive Q2 chimera
which, unlike Q1, was able to respond in vivo to the inducer
molecules. This, synthetic Q2 protein constitutes the first
shikimate-dependent transcriptional regulator described so far.
Our finding that it is possible to construct a transcriptional
regulator by fusing an appropriate DNA-binding domain to an
enzyme that recognizes the target compound, paves the way for a
novel rational approach to create new a` la carte regulatory proteins.
During the course of evolution of the BzdR regulator, the Q2-like
ancestral protein proposed likely suffered additional mutations
preventing its recognition of shikimate while increasing its binding
affinity for benzoyl-CoA, the inducer and first intermediate of the
catabolic pathway controlled by BzdR.
Besides recreating a plausible pathway for the evolution of an
enzyme into a transcriptional regulator, our findings also support
the notion that enzymes preceded the emergence of the regulatory
systems that control their expression.
Supporting Information
Figure S1 Study of the oligomerization state of NBzdR
(A) and NBzdRL (B) proteins in solution. Sedimentation
equilibrium data (grey dots) and best fit analysis assuming a
protein dimer (black line) and monomer (red line) species. The
lower panels show the difference between estimated values and
experimental data for protein dimers (residuals). The data indicate
that NBzdR and NBzdRL proteins are dimers, demonstrating that
BzdR dimerization is an intrinsic property of the N-terminal
domain.
(TIF)
Figure S2 Conformational changes in CBzdR induced
by benzoyl-CoA binding. Intrinsic fluorescence of His6-CBzdR
as a function of benzoyl-CoA (Bz-CoA) concentration. Data points
represent the decrease in the His6-CBzdR (7.5 mM) fluorescence
emission maximum (312 nm) expressed in arbitrary units (a.u.)
upon excitation at 275 nm in the presence of increasing
concentrations of Bz-CoA. Insets, fitting Bz-CoA binding to
His6-CBzdR [P] to a single site model. This result suggests that
benzoyl-CoA induces a conformational change in CBzdR and,
therefore, that CBzdR retains its effector-binding ability in the
absence of the NBzdR domain, thus behaving as an independent
functional domain.
(TIF)
Figure S3 Study of the oligomerization state of CBzdR
and Q1 proteins in solution. Sedimentation coefficient
distribution c(s) corresponding to the sedimentation velocity of
purified His6-CBzdR (broken blue line) and His6-Q1 (solid blue
line) proteins. The protein concentration distribution pattern (c(s))
and sedimentation coefficient (S) are represented in the graph. The
standard s-value of the protein did not change significantly with
protein concentration over the range examined (1-30 mM). The
Q1 protein behaved as a single species with an s-value 3.7 S
consistent with a protein dimer, whereas CBzdR behaved as a
single species with an s-value of 1.8 S compatible with a globular
monomer.
(TIF)
Figure S4 Shikimate kinase activity of E. coli SKI and
CBzdR, Q1 and Q2 proteins. A. SK activities are shown for
the purified His6-SKI (red line), His6-CBzdR (orange line), His6-
Q1 (black line) and His6-Q2 (green line). Despite its conserved
similarity with SKs, CBzdR showed no detectable shikimate kinase
activity. B. Growth curves for E. coli ALO807strain defective in
the aroL and aroK genes harboring plasmid pQE32-His6Q1
(expresses the His6-Q1 protein) (red lines) or the control pQE32
plasmid (green lines). Cells were grown in M63 minimal medium
supplemented with 30 mM glycerol in the presence (continuous
lines) or absence (discontinuous lines) of 0.4% (w/v) casamino
acids. The results of a single representative experiment are shown,
and values were reproducible in three separate experiments with
standard deviation values of ,10%. These results demonstrate
that the Q1 protein retains SK activity in the SK defective mutant
strain.
(TIF)
Figure S5 Diagram showing the conformational chang-
es the SK enzyme undergoes during a catalytic cycle. The
SK enzyme shows the LID region (white), the NB region (green)
responsible for ATP-recognition, the ESB region (blue) involved in
shikimate recognition, and the RC region (red), which constitutes
the rest of the SK structure. A. ‘‘Unloaded conformation’’ of the
SK enzyme. B. ‘‘Loaded conformation’’ of SK in the presence of
shikimate. c. Structural conformation of the SK in the presence of
ATP-Mg2+ and shikimate. Thick black arrow represents the
release of the two products of the reaction, 3P-shikimate and ADP,
and the recovery of the initial ‘‘unloaded conformation’’ of the SK
enzyme. Adapted from Hatmann et al. [17]
(TIF)
Acknowledgments
The authors thank to V. de Lorenzo for critical reading of the manuscript
and inspiring discussions, A. Valencia for the technical assistance and
Secugen S.L. for help with the gene sequencing procedures.
Evolution of the BzdR Regulator
PLOS ONE | www.plosone.org 8 March 2013 | Volume 8 | Issue 3 | e57518
Author Contributions
Conceived and designed the experiments: MC GD-R ED. Performed the
experiments: GD-R JMM CA. Analyzed the data: MC ED GR.
Contributed reagents/materials/analysis tools: JMM GR CA. Wrote the
paper: MC ED JLG.
References
1. McAdams HH, Srinivasan B, Arkin AP (2004) The evolution of genetic
regulatory system in bacteria. Nat Rev Gene 5: 169–178.
2. Commichau FM, Stu¨lke J (2008) Trigger enzymes: bifunctional proteins active
in metabolism and in controlling gene expression. Mol Microbiol 67: 692–702.
3. Lohr D, Lo´pez J (1995) GAL4/GAL80-dependent nucleosome disruption/
deposition on the upstream region of the yeast GAL1-10 and GAL80 genes.
J Biol Chem 270: 27671–27678.
4. Aravind L, Koonin EV (1998) Eukaryotic transcription regulators derive from
ancient enzymatic domains. Curr Biol 8: R111–R113.
5. Allison SL, Phillips AT (1990) Nucleotide sequence of the gene encoding the
repressor for the histidine utilization genes of Pseudomonas putida. J Bacteriol 172:
5470–5476.
6. Quail MA, Dempsey CE, Guest JR (1994) Identification of a fatty acyl
responsive regulator (FarR) in Escherichia coli. FEBS Lett 356: 183–187.
7. Barraga´n MJ, Bla´zquez B, Zamarro MT, Manchen˜o JM, Garcı´a JL, et al. (2005)
BzdR, a repressor that controls the anaerobic catabolism of benzoate in Azoarcus
sp. CIB, is the first member of a new subfamily of transcriptional regulators.
J Biol Chem 280: 10683–10694.
8. Durante-Rodrı´guez G, Valderrama JA, Manchen˜o JM, Rivas G, Alfonso C, et
al. (2010) Biochemical characterization of the transcriptional regulator BzdR
from Azoarcus sp. CIB. J Biol Chem 285: 35694–35705.
9. Sambrook J, Russell DW (2001) Molecular Cloning: A Laboratory Manual.,
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
10. Miller JH (1972) Experiments in Molecular Genetics. Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY.
11. Millar G, Lewendon A, Hunter MG, Coggins JR (1986) The cloning and
expression of the aroL gene from Escherichia coli K12. Biochem J 237: 427–437.
12. Durante-Rodrı´guez G, Zamarro MT, Garcı´a JL, Dı´az E, Carmona M (2006)
Oxygen-dependent regulation of the central pathway for the anaerobic
catabolism of aromatic compounds in Azoarcus sp. CIB. J Bacteriol 188: 2343–
2354.
13. Lineweaver H, Burk D (1934) The determination of enzyme dissociation
constants. J Am Chem Soc 56: 658–666.
14. De Feyter R (1987) Shikimate kinase from Escherichia coli K12. Methods Enzymol
142: 355–361.
15. Whipp MJ, Pittard AJ (1995) A reassessment of the relationship between aroK-
aroL-encoded shikimate kinase enzymes of Escherichia coli. J Bacteriol 177: 1627–
1629.
16. Vonhein C, Schlaiderer GJ, Schulz GE (1995) Movie of the structural changes
during a catalytic cycle of nucleoside monophosphate kinases. Structure 3: 483–
490.
17. Hartmann DM, Bourenkov GP, Oberschall A, Strizhov N, Bartunik HD (2006)
Mechanism of phosphoryl transfer catalyzed by shikimate kinase from
Mycobacterium tuberculosis. L Mol Biol 364: 411–423.
18. Løbner-Olensen A, Marinus MG (1992) Identification of the gene (aroK)
encoding shikimic acid kinase I of Escherichia coli. J Bacteriol 174: 525–529.
19. Krell T, Coggins JR, Lapthorn AJ (1998) The three-dimensional structure of
shikimate kinase. J Mol Biol 278: 983–997.
20. Jensen RA (1974) Enzyme recruitment in evolution of new function. Annu Rev
Microbiol 30: 409–425.
21. O’Brien PJ, Herschlag D (1999) Catalytic promiscuity and the evolution of new
enzymatic activities. Chem Biol 6: R91–R105.
22. Peisajaovich S, Tawfik D (2007) Protein engineers turned evolutionists. Nat
Meth 4: 991–994.
23. Galva˜o TC, Mencı´a M, de Lorenzo V (2007) Emergence of novel functions in
transcriptional regulators by regression to stem protein types. Mol Microbiol 65:
907–919.
24. Aharoni A, Gaidukov L, Khersonsky O, Gould SM, Roodveldt C, et al. (2005)
The ‘evolvability’ of promiscuous protein functions. Nat Genet 37: 73–76.
25. Coggins JR, Boocock MR, Chaudhuri S, Lambert JM, Lumsden J, et al. (1987)
The arom multifunctional enzyme from Neurospora crassa. Methods Enzymol 142:
325–341.
26. Fucile G, Falconer S, Christendat D (2008) Evolutionary diversification of plant
shikimate kinase gene duplicates. PLoS Genetics 4: e1000292.
27. Vinella D, Gagny B, Joseleau-Petit D, D’Ari R, Cashel M (1996) Mecillinam
resistance in Escherichia coli is conferred by loss of a second activity of the AroK
protein. J Bacteriol 178: 3818–3828.
28. Cazalet C, Rusniok C, Bru¨ggemann H, Zidane N, Magnier A, et al. (2004)
Evidence in the Legionella pneumophila genome for exploitation of host cell
functions and high genome plasticity. Nat Genet 36: 1165–1173.
29. Silhavy TJ, Berman ML, Enquist LW (1984) Experiments with gene fusions.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
30. Ferra´ndez A, Garcı´a JL, Dı´az E (2000) Transcriptional regulation of the
divergent paa catabolic operons for phenylacetic acid in Escherichia coli.
Characterization of a new aerobic hybrid patway. J Biol Chem 275: 12214–
12222.
31. Lo´pez-Barraga´n MJ, Carmona M, Zamarro MT, Thiele B, Boll M, et al. (2004)
The bzd gene cluster, coding for anaerobic benzoate catabolism, in Azoarcus sp.
strain CIB. J Bacteriol 186: 5762–5774.
32. Manoil C, Beckwith J (1985) TnphoA: a transposon probe for protein export
signals. Proc Natl Acad Sci U S A 82: 8129–8133.
33. Ferra´ndez A, Min˜ambres B, Garcı´a B, Olivera ER, Luengo JM, et al. (1998)
Catabolism of phenylacetic acid in Escherichia coli. Characterization of a new
aerobic hybrid pathway. J Biol Chem 273: 25974–25986.
Evolution of the BzdR Regulator
PLOS ONE | www.plosone.org 9 March 2013 | Volume 8 | Issue 3 | e57518
